HEMOSTAD-INC: Efficacy and Safety of Hemostatic Methods in Distal Radial Artery Approach for Cardiac Catheterization
Study Details
Study Description
Brief Summary
Comparison of PreludeSYNC distal and Modified Terumo Radial Band in patients with distal radial approach.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
N/A |
Detailed Description
INTRODUCTION AND BACKGROUND
Distal radial access at the level of the anatomical snuffbox and dorsal region of the hand has currently positioned itself as a viable and safe approach for procedures in interventional cardiology, whether diagnostic, simple, or complex angioplasties. We know that this approach method mainly reduces the occlusion rate of the proximal radial artery, among other advantages; however, we still do not have scientific evidence on the various hemostasis methods for this approach. Practice varies between centers and countries and hemostasis methods vary from an elastic compression bandage to the use of devices manufactured specifically for this approach such as the PreludeSYNC DISTAL or modification of devices manufactured for proximal radial hemostasis such as the TR band. In this clinical trial, we intend to analyze the efficacy and safety of two hemostasis methods in patients who require an interventional procedure (PredludeSYNC DISTAL vs modified TR band), to date, there is no clinical trial that compares these methods face to-face in relation to their efficacy and safety. Retrospective studies indicate that both methods are effective in reducing radial artery occlusion and are safe in reducing the bleeding/hematoma rate.
THE PURPOSE OF THE STUDY To compare the efficacy (distal radial artery occlusion) and safety (hematoma/bleeding) of two devices of distal radial hemostasis (PreludeSYNC distal and TR band) in patients undergoing percutaneous coronary intervention.
STUDY DESIGN Experimental, randomized, prospective, longitudinal, prolective, and comparative.
SUBJECTS OF STUDY Patients from the Ignacio Chávez National Institute of Cardiology who will undergo distal radial percutaneous coronary intervention/angiography.
METHODOLOGY After signing the informed consent, patients will be randomized by balanced block methods to: 1) Hemostasis using the PreludeSYNC distal device, or 2) Hemostasis using the Modified Radial Band device.
PRIMARY OUTCOME To compare the efficacy (distal radial artery occlusion) and safety (hematoma/bleeding) of PreludeSYNC distal versus Modified Terumo Radial Band in distal radial approach.
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Experimental: Modified Terumo Radial Band A standard hemostatic device used for proximal radial approach. The hard plastic component is removed to achieve better attachment in the distal radial approach. Clean and dry the puncture site. The introducer is withdrawn 2 cm. Place the device on the patient's hand depending on the approach side. Terumo logo is positioned toward the little finger side. The green mark is positioned 1 cm proximal to the puncture site. The bands are adjusted and fixed around the wrist. The Terumo syringe is filled with 15 ml of air. The balloon of the device is slowly inflated through the valve while the introducer is slowly withdrawn simultaneously. Once the introducer is completely withdrawn, the balloon continues to be inflated until the absence of bleeding is verified. Once hemostasis is achieved, the patient must be able to move his fingers and wrist without bleeding. If bleeding is observed, the balloon is inflated to achieve adequate hemostasis. |
Device: Hemostatic device for distal radial approach.
Hemostasis after distal radial approach is done with one of two devices, one of them is designed specifically for the distal radial approach; the other is not but a modified technique with the last one could be helpful.
Other Names:
|
| Active Comparator: PreludeSYNC distal A specific hemostatic device, designed for distal radial approach. Clean and dry the puncture site. Selection and preparation of the PreludeSYNC distal device according to the approach side. The introducer is withdrawn 2cm. The hemostasis device is placed on the patient's hand. Bands position: 1) little finger side; 2) thumb side; 3) between the thumb and the index finger. The circular mark of the balloon is positioned 1cm proximal to the puncture site. Bands are adjusted and fixed. The syringe is filled with 10 ml of air. The balloon of the device is slowly inflated while the introducer is slowly withdrawn simultaneously. Once the introducer is completely withdrawn, the balloon continues to be inflated until the absence of bleeding is verified. Once hemostasis is achieved, the patient must be able to move his fingers and wrist without bleeding. If bleeding is observed, the balloon should be inflated to achieve adequate hemostasis. |
Device: Hemostatic device for distal radial approach.
Hemostasis after distal radial approach is done with one of two devices, one of them is designed specifically for the distal radial approach; the other is not but a modified technique with the last one could be helpful.
Other Names:
|
Outcome Measures
Primary Outcome Measures
- To compare the incidence of proximal radial artery occlusion assessed by ultrasound and the incidence of hematoma/bleeding assessed clinically by EASY scale of PreludeSYNC distal versus Modified Terumo Radial Band in distal radial approach. [24 hours after the procedure. Patients with radial occlusion at 24 hours will be follow at 30 days.]
At 24 hours after the procedure, patients will be evaluated by interrogation, physical exam and ultrasonography. The absence of Doppler flow in the proximal radial artery at wrist level will define the occlusion of the radial artery. The EASY scale will be used to classify the severity of the hematoma in degrees from I to V according to the extension.
Secondary Outcome Measures
- Incidence of distal and proximal radial artery occlusion at 24 hours after the procedure. [24 hours after the procedure.]
Evaluated by clinical signs and doppler.
- Radial arterial patency at 30 days in patients with obstruction at 24 hours. [30 days after the procedure]
Evaluated by clinical signs and ultrasound doppler.
- Incidence of hematoma at the approach site. [24 hours after the procedure.]
Evaluated by clinical signs. Classified according to EASY scale.
- Bleeding at the access site. [24 hours after the procedure.]
Evaluated by clinical signs.
- Neurological sequelae. [24 hours after the procedure.]
Evaluated by clinical signs.
- Incidence of radial artery pseudoaneurysms. [24 hours after the procedure.]
Evaluated by clinical signs and ultrasound doppler.
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Coronary artery disease including chronic coronary syndrome or acute coronary syndrome.
-
Cardiovascular disease that requires coronary angiography in its approach.
Exclusion Criteria:
-
Cardiogenic shock.
-
Lesions in venous or arterial hemoducts.
-
Impossibility to provide informed consent.
-
Chronic kidney disease on hemodialysis through arteriovenous fistula at the same site where the approach is planned.
-
Severe chronic renal failure (GFR less than 30 ml/min/m2)
-
Patients diagnosed with cancer.
-
Patient with rheumatological and hematological pro-thrombotic disorders.
-
Non-hydrophilic radial introducer.
-
Failed cannulation of the radial artery with an introducer.
-
Successful trans-radial access that is crossed over to the femoral approach.
-
Patients with an interventional procedure using a radial approach in the previous 30 days.
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Instituto Nacional de Cardiologia Ignacio Chávez | Mexico City | Mexico | 14080 |
Sponsors and Collaborators
- Instituto Nacional de Cardiologia Ignacio Chavez
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 21-1255